Showing results (1201-1210 of 1,334) with videos related to

Sort By:
Pageof 134
European Journal of Cancer (Oxford, England : 1990)|January 7, 2017
Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patientsIedan R N Verly, André B P van Kuilenburg, Nico G G M Abeling, et al.
European Child & Adolescent Psychiatry|December 15, 2020
Twelve-month service use, suicidality and mental health problems of European adolescents after a school-based screening for current suicidalityMichael Kaess, N Schnyder, C Michel, et al.
Experimental Hematology|May 25, 2016
Epigenetic therapy as a novel approach for GFI136N-associated murine/human AMLLacramioara Botezatu, Lars C Michel, Anne Helness, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2013
Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer ConsortiumC Michel Zwaan, Carmelo Rizzari, Francoise Mechinaud, et al.
Translational Oncology|March 5, 2021
High-throughput drug screening reveals Pyrvinium pamoate as effective candidate against pediatric MLL-rearranged acute myeloid leukemiaPriscilla Wander, Susan T C J M Arentsen-Peters, Sandra S Pinhanҫos, et al.
Targeted Oncology|December 11, 2025
Idasanutlin in Combination with Chemotherapy or Venetoclax in Pediatric and Young Adult Patients with Relapsed/Refractory Solid Tumors (iMATRIX Idasa): Results of a Phase I/II, Multicenter, Multi-arm StudyAlba Rubio-San-Simón, Lynley V Marshall, Francois Doz, et al.
Gastroenterology|November 14, 2025
Changes in Liver Disease Etiology Support a Lower Alpha-Fetoprotein Threshold for Hepatocellular Carcinoma ScreeningNicole J Kim, Muyi Li, Philip Vutien, et al.
British Journal of Haematology|August 4, 2017
Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapyMichaela Kuhlen, Kirsten Bleckmann, Anja Möricke, et al.
Blood|January 4, 2008
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosisBrian V Balgobind, Pieter Van Vlierberghe, Ans M W van den Ouweland, et al.
Nature Communications|July 17, 2024
Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasmsEline J M Bertrums, Jurrian K de Kanter, Lucca L M Derks, et al.
Pageof 134